Five high ranking institutions including University Hospitals in Paris, Lyon, Bordeaux and Nimes (France), will be treating 154 patients with RENOVA's Linear Shockwave Technology. ThisMulti-Center Clinical Trial will comprise a long term follow-up.

The study is coordinated by CHUR de NÎMES,with Prof. Stéphane Droupy Head of Andrology and Sexual Medicine Committee at the French Urology Association (AFU) and the author of dozens of publications in the field.

The clinical study is being funded by the French Government and is recognized as a significant step in the ongoing research of the far reaching potential of LISW treatment. The largest Multi Center Clinical Trial of Low Intenisty Shockwave for ED is to take place in France beginning September.

About DirexGroup:
DirexGroup and Initia have created an alliance that specializes in introducing innovative high-technology devices for urologists in all worldwide markets. DirexGroup, established over 27 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs. Our products are characterized by reliability, modularity and transportability combined with cost effectiveness and ease of use. A worldwide network of committed service centers assure competent support and maintenance. Contact DirexGroup at: This email address is being protected from spambots. You need JavaScript enabled to view it.